Zacks Company Profile for Fortress Biotech, Inc. (FBIO : NSDQ) |
|
|
|
Company Description |
Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.
Number of Employees: 101 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $1.93 |
Daily Weekly Monthly
 |
20 Day Moving Average: 214,538 shares |
Shares Outstanding: 29.57 (millions) |
Market Capitalization: $57.07 (millions) |
Beta: 1.75 |
52 Week High: $2.89 |
52 Week Low: $1.33 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-7.21% |
-9.99% |
12 Week |
26.97% |
10.07% |
Year To Date |
-4.69% |
-9.96% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Lindsay A. Rosenwald - Chief Executive Officer; Chairman and President
Michael S. Weiss - Executive Vice Chairman; Strategic Development
David Jin - Chief Financial Officer and Head of Corporate Deve
Jimmie Harvey - Director
Malcolm Hoenlein - Director
|
|
Peer Information
Fortress Biotech, Inc. (CORR.)
Fortress Biotech, Inc. (RSPI)
Fortress Biotech, Inc. (CGXP)
Fortress Biotech, Inc. (BGEN)
Fortress Biotech, Inc. (GTBP)
Fortress Biotech, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 34960Q307
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
|
|
Share - Related Items
Shares Outstanding: 29.57
Most Recent Split Date: 10.00 (0.07:1)
Beta: 1.75
Market Capitalization: $57.07 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.24 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.29 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/12/25 |
|
|
|
|